Dr. R. Masereeuw

Pagina-navigatie:

Main
Completed research (1)
Publications (54)

filter results

Type

Date

Accessibility

Institution

Radboud University Nijmegen (54)

1-10 out of 54 results by:date

Save search results

Effect of drugs on renal development (2011)

Authors:	Schreuder, M.F.; Bueters, R.R.G.; Huigen, M.C.; Russel, F.G.M.; Masereeuw, R.; Heuvel, L.P.W.J. van den
In:	Clinical Journal of the American Society of Nephrology, 6, 212 - 217. ISSN 1555-9041.

Mass spectrometry analysis of hepcidin peptides in experimental mouse models (2011)

Authors:	Tjalsma, H.; Laarakkers, C.M.; van Swelm, R.P.; Theurl, M.; Theurl, I.; Kemna, E.H.J.M.; van der Burgt, Y.E.; Venselaar, H.; Dutilh, B.E.; Russel, F.G.M.; Weiss, G.; Masereeuw, R.; Fleming, R.E.; Swinkels, D.W.
In:	PLoS ONE, 6. ISSN 1932-6203.

Preserved response to diuretics in rosiglitazone-treated subjects with insulin resistance: a randomized double-blind placebo-controlled crossover study (2011)

Authors:	Rennings, A.J.M.; Russel, F.G.M.; Li, Y.; Deen, P.M.T.; Masereeuw, R.; Tack, C.J.J.; Smits, P.
In:	Clinical Pharmacology & Therapeutics, 89, 587 - 594. ISSN 0009-9236.

Rapid, nongenomic stimulation of multidrug resistance protein 2 (Mrp2) activity by glucocorticoids in renal proximal tubule (2011)

Authors:	Prevoo, B.; Miller, D.S.; van de Water, F.M.; Wever, K.E.; Russel, F.G.M.; Flik, G.; Masereeuw, R.
In:	Journal of Pharmacology and Experimental Therapeutics, 338, 362 - 371. ISSN 0022-3565.

Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations (2011)

Authors:	Mutsaers, R.; van den Heuvel, L.P.; Ringens, L.H.; Dankers, A.C.A.; Russel, F.G.M.; Wetzels, J.F.M.; Hoenderop, J.G.J.; Masereeuw, R.
In:	PLoS ONE, 6. ISSN 1932-6203.

Urinary protein profiling in hyperactive delirium and non-delirium cardiac surgery ICU patients (2011)

Authors:	van den Boogaard, M.; van Swelm, R.P.; Russel, F.G.M.; Heemskerk, S.; van der Hoeven, J.G.; Masereeuw, R.; Pickkers, P.
In:	Proteome Science, 9, 13. ISSN 1477-5956.

Therapeutic implications of renal anionic drug transporters. (2010)

Authors: Masereeuw, R.; Russel, F.G.M.
In: Pharmacology and Therapeutics, 126, 200 - 216. ISSN 0163-7258.

Abstract:
One of most important functions of the kidney concerns the clearance of endogenous waste products, exogenously administered drugs as well as environmental exposures. In addition to glomerular filtration, active tubular secretion is an efficient mechanism for extracting compounds from the circulation

Authors:	Masereeuw, R.; Russel, F.G.M.
In:	Pharmacology and Therapeutics, 126, 200 - 216. ISSN 0163-7258.

Deficiency of either P-glycoprotein or breast cancer resistance protein protect against acute kidney injury. (2010)

Authors:	Huls, M.; Schoeber, J.P.H.; Verfaillie, C.M.; Luttun, A.; Ulloa-Montoya, F.; Menke, A.L.; Bolderen, L.R. van; Woestenenk, R.M.; Merkx, G.F.M.; Wetzels, J.F.M.; Russel, F.G.M.; Masereeuw, R.
In:	Cell Transplantation, 19, 1195 - 1208. ISSN 0963-6897.

Abstract:

The kidney has a high capacity to regenerate after ischemic injury via several mechanisms, one of which involves bone marrow-derived (stem) cells. The ATP binding cassette transporters, P-glycoprotein and breast cancer resistance protein, are determinants for the enriched stem and progenitor cell fr

Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. (2010)

Authors: Reichel, V.; Klas, J.; Fricker, G.; Masereeuw, R.
In: Journal of Neurochemistry, 115, 200 - 208. ISSN 0022-3042.

Abstract:
The choroid plexuses (CP) are responsible for transport of micronutrients into brain and clearance of toxic compounds, in addition to its barrier function and production of CSF. Multidrug resistance-associated protein (Mrp) 4 is one transport protein highly expressed in CP tissue and is characterize

Authors:	Reichel, V.; Klas, J.; Fricker, G.; Masereeuw, R.
In:	Journal of Neurochemistry, 115, 200 - 208. ISSN 0022-3042.

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention. (2010)

Authors:	Vegt, E. de; Jong, M. de; Wetzels, J.F.M.; Masereeuw, R.; Melis, M.; Oyen, W.J.G.; Gotthardt, M.; Boerman, O.C.
In:	Journal of Nuclear Medicine, 51, 1049 - 1058. ISSN 0161-5505.

Abstract:

Peptide-receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs such as octreotide is an effective therapy against neuroendocrine tumors. Other radiolabeled peptides and antibody fragments are under investigation. Most of these compounds are cleared through the kidneys and reabso

Pages:

previous

< 1 2 3 4 5 6 >